A detailed history of Horizon Kinetics Asset Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Horizon Kinetics Asset Management LLC holds 59,382 shares of BMY stock, worth $3.43 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
59,382
Previous 45,018 31.91%
Holding current value
$3.43 Million
Previous $1.87 Million 64.42%
% of portfolio
0.05%
Previous 0.04%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $569,676 - $743,337
14,364 Added 31.91%
59,382 $3.07 Million
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $61,582 - $81,074
1,530 Added 3.52%
45,018 $1.87 Million
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $45,676 - $51,788
952 Added 2.24%
43,488 $2.36 Million
Q4 2023

Feb 15, 2024

BUY
$48.48 - $57.85 $7,514 - $8,966
155 Added 0.37%
42,536 $2.18 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $8,683 - $9,709
-150 Reduced 0.35%
42,381 $2.46 Million
Q1 2023

May 12, 2023

SELL
$65.71 - $74.53 $324,410 - $367,954
-4,937 Reduced 10.4%
42,531 $2.95 Million
Q4 2022

Feb 07, 2023

SELL
$68.48 - $81.09 $22,803 - $27,002
-333 Reduced 0.7%
47,468 $3.41 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $28 - $16,904
220 Added 0.46%
47,801 $3.4 Million
Q2 2022

Aug 05, 2022

SELL
$72.62 - $79.98 $20,551 - $22,634
-283 Reduced 0.59%
47,581 $3.66 Million
Q1 2022

May 13, 2022

SELL
$61.48 - $73.72 $7,377 - $8,846
-120 Reduced 0.25%
47,864 $3.5 Million
Q4 2021

Feb 15, 2022

BUY
$53.63 - $62.52 $52,289 - $60,957
975 Added 2.07%
47,984 $2.99 Million
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $41,419 - $48,517
-700 Reduced 1.47%
47,009 $2.78 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $742 - $809
-12 Reduced 0.03%
47,709 $3.19 Million
Q1 2021

May 11, 2021

SELL
$59.34 - $66.74 $1,186 - $1,334
-20 Reduced 0.04%
47,721 $3.01 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $180,899 - $204,992
-3,133 Reduced 6.16%
47,741 $2.96 Million
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $9,188 - $10,182
-160 Reduced 0.31%
50,874 $3.07 Million
Q2 2020

Aug 14, 2020

SELL
$54.82 - $64.09 $103,500 - $121,001
-1,888 Reduced 3.57%
51,034 $3 Million
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $111,174 - $161,562
-2,396 Reduced 4.33%
52,922 $2.95 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $344,470 - $449,330
7,000 Added 14.49%
55,318 $3.55 Million
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $3,635 - $4,310
-85 Reduced 0.18%
48,318 $2.45 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $72,061 - $79,684
1,615 Added 3.45%
48,403 $2.2 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $2.11 Million - $2.52 Million
46,788 New
46,788 $2.23 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Horizon Kinetics Asset Management LLC Portfolio

Follow Horizon Kinetics Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Kinetics Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Kinetics Asset Management LLC with notifications on news.